Overview
MAGE-3 (271-279) is a highly specific peptide derived from melanoma antigens encoded by MAGE-3, and is classified as a HLA-A*0201, restricted peptide. This peptide is essential for research in immunology and cancer studies, particularly for those focusing on melanoma. With its unique properties, MAGE-3 (271-279) offers valuable insights into T-cell responses and immune recognition. By purchasing this peptide, you gain access to a vital tool for enhancing your research capabilities.
Key Features
- Derived from melanoma antigens for targeted research
- HLA-A*0201-restricted for specificity in studies
- Available in a convenient 1 mg size for versatile applications
- Sourced from high-quality materials to ensure integrity
- Ideal for use in immune response and vaccine development studies
Specifications
| Property | Value |
|---|---|
| Peptide Length | 9 amino acids |
| Purity | ≥95% |
| Form | Powder |
| Storage Conditions | -20°C |
FAQ
What applications can MAGE-3 (271-279) be used for?
This peptide is primarily utilized in immunology research, particularly in studies related to melanoma and T-cell activation. It’s beneficial for vaccine development and in understanding immune responses.
How should MAGE-3 (271-279) be stored?
To preserve its integrity, store MAGE-3 (271-279) at -20°C, ensuring the peptide remains stable for future use in your experiments.
What is the recommended dosage for experiments?
The specific dosage can vary based on the experiment. However, starting with a concentration that allows for proper T-cell stimulation is advisable. Always consult your experimental protocol for guidance.
Don’t miss out on the opportunity to enhance your research with MAGE-3 (271-279). This peptide is available for direct purchase today. Enhance your studies in immunology and melanoma by adding this essential peptide to your toolkit.
Related Products
- PKG Substrate [RKRSRAE], Glasstide
- Autocamtide-2 [KKALRRQETVDAL]
- CREBtide [KRREILSRRPSYR], 5-FAM labeled
Browse more in Peptides.




Reviews
There are no reviews yet.